Skip to main content
OpenTrials

Clinical trial condition

Recurrent Non-Small Cell Lung Carcinoma

Explore clinical trials studying Recurrent Non-Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

26 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Non-Small Cell Lung Carcinoma trial results

Completed

Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer

NCT01866410

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer

NCT00387465

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sidney Kimmel Cancer Center San Diego, California, United States
  • Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Completed

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

NCT01727076

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
  • Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details
Completed

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

NCT01294306

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +19 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View Trial Details

Related conditions